BioSpace News Archive

Biotech Bay

MedGenome Expands its NGS Capabilities and Forays Into Single-Cell Sequencin-

The new additions increase MedGenome’s data-generation capability by a factor of five.

January 31, 2018
·
2 min read
Business

Biodesix Announces PD-L1 Collaboration With Professor Fred R. Hirsch

The data were presented last week at the ASCO-SITC conference.

January 31, 2018
·
2 min read
Manchester Imaging Raises £600k to Launch Dental Diagnostic Software

The investment will support the development and commercial launch of the company’s first suite of software products that use machine learning and computer vision processes to automatically detect the very early signs of tooth decay, which can go unseen by dentists.

January 31, 2018
·
2 min read
Drug Development

BriaCell Update: Early Evidence of Efficacy and Safety of Bria-IMT

The company is pleased to provide a further update on its ongoing clinical trial of Bria-IM.

January 31, 2018
·
7 min read
MedXperience: Organizing Committee Welcomes 24 European Delegations to Program Unveiling

On January 22, twenty-four delegations from a number of European countries joined the organizing committee.

January 31, 2018
·
3 min read
6,000 Subjects Analysed by AMRA Now Available for Researchers Through UK Biobank

Scientists and researchers intending to use the data in research related to prevention, diagnosis, and treatment of illness are now able to apply for unlimited access via the UK Biobank website.

January 31, 2018
·
3 min read
Business

ESPERITE and BGI Genomics Sign a Strategic Agreement to Offer Whole Genome Sequencing on a Large Scale

BGI has accepted to finance Esperite’s access to the technology.

January 31, 2018
·
4 min read
Drug Development

MPI’s Spinout Oncology Venture Announces Positive Interim Results From a Phase I/II DRP Guided Study of Liplacis in Heavily Pretreated Breast Cancer Patients

The selection of patients for the Phase 1/2 study is aided by the MPI developed DRP® companion diagnostic tool, allowing inclusion of those patients most likely to respond to treatment.

January 31, 2018
·
7 min read
Policy

Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment

Fexinidazole would be first all-oral treatment* under investigation for both first and second stages of sleeping sickness.

January 31, 2018
·
6 min read
Deals

Solid Biosciences Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Overallotment Option

J.P. Morgan, Goldman Sachs & Co. LLC and Leerink Partners acted as joint book-running managers of the offering,

January 31, 2018
·
2 min read